These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3000728)

  • 21. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors.
    Hershkovitz E; Marbach M; Bosin E; Levy J; Roberts CT; LeRoith D; Schally AV; Sharoni Y
    J Clin Endocrinol Metab; 1993 Oct; 77(4):963-8. PubMed ID: 8408472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression.
    Miller DL; el-Ashry D; Cheville AL; Liu Y; McLeskey SW; Kern FG
    Cell Growth Differ; 1994 Dec; 5(12):1263-74. PubMed ID: 7696175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
    Arteaga CL; Osborne CK
    Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.
    Murphy LJ; Sutherland RL; Stead B; Murphy LC; Lazarus L
    Cancer Res; 1986 Feb; 46(2):728-34. PubMed ID: 3000583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth.
    Huber M; Poulin R
    J Clin Endocrinol Metab; 1996 Jan; 81(1):113-23. PubMed ID: 8550737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.
    Foekens JA; Portengen H; Janssen M; Klijn JG
    Cancer; 1989 Jun; 63(11):2139-47. PubMed ID: 2541884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
    Fitzpatrick SL; LaChance MP; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
    Yamada Y; Serrero G
    J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.
    Daly RJ; Harris WH; Wang DY; Darbre PD
    Cell Growth Differ; 1991 Sep; 2(9):457-64. PubMed ID: 1661135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
    Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
    Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen.
    van der Burg B; Rutteman GR; Blankenstein MA; de Laat SW; van Zoelen EJ
    J Cell Physiol; 1988 Jan; 134(1):101-8. PubMed ID: 3275677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.
    Martin JL; Coverley JA; Pattison ST; Baxter RC
    Endocrinology; 1995 Mar; 136(3):1219-26. PubMed ID: 7532580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.
    Clarke R; Brünner N; Katz D; Glanz P; Dickson RB; Lippman ME; Kern FG
    Mol Endocrinol; 1989 Feb; 3(2):372-80. PubMed ID: 2710138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha 1-antitrypsin blocks the release of transforming growth factor-alpha from MCF-7 human breast cancer cells.
    Yavelow J; Tuccillo A; Kadner SS; Katz J; Finlay TH
    J Clin Endocrinol Metab; 1997 Mar; 82(3):745-52. PubMed ID: 9062476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG; Hosick HL; Ethier SP
    J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laminin inhibits estrogen action in human breast cancer cells.
    Woodward TL; Lu H; Haslam SZ
    Endocrinology; 2000 Aug; 141(8):2814-21. PubMed ID: 10919267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.